http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6069017-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39ae96c0ecc22ff90ff986371a3cea0f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
filingDate 1984-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b46f34cd38c4e27de0f7d645b6131392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a585cd6259ac332635b157bc1352a0a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b9c12967bb1b66144afd9c3d99cdbf9
publicationDate 1985-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6069017-A
titleOfInvention Antispasmodic
abstract PURPOSE: An antispasmodic agent that contains, as an active ingredient, an α-aryl-α-pyridylfatty acid derivative such as 4-(N,N-dimethylamino)-2-phenyl- 2-(2-pyridyl)valeramide, thus showing excellent oral absorption. n CONSTITUTION: The objective antispasmodic contains, as an active ingredient, an α-aryl-α-pyridylfatty acid derivative of the formula (R 1 is cyano, carbamoyl; R 2 is H, halogen; R 3 is H, alkyl; one of R 4 and R 5 is H and the other is alkyl; R 6 is H, alkyl; R 7 is alkyl, R 6 and R 7 may incorporate together N to form a saturated heterocyclic ring where in case that R 1 is cyano and R 6 and R 7 are alkyl, R 2 is halogen and R 3 is alkyl) or its salt. The resultant compound shows excellent antispasmodic action with no hypotension on injection and reduced action on central nervous system. n COPYRIGHT: (C)1985,JPO&Japio
priorityDate 1983-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3025060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416222828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234802254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655

Total number of triples: 20.